Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Which dressing hurts less? study compares lomatuell pro and UrgoTul

NCT ID NCT03897465

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested two types of wound dressings—Lomatuell Pro and UrgoTul—on 183 people with acute wounds like cuts, scrapes, or minor burns. The main goal was to see which dressing caused less pain when removed. Patients rated their pain during the first dressing change, and the study also looked at how well the wounds healed over three weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Lomatuell Pro dressing and UrgoTul dressing
What this could lead to
If one dressing proves less painful, it could improve patient comfort during wound care.
What could go wrong
This is a small, completed trial comparing two similar products, so results may not apply to all wounds or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

183 people

The number who actually took part.

Started

Feb 2019

Finished

Dec 2020

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Acute wound: traumatic wound (dermabrasion, skin tears, other), small burns 1st and 2nd degree requiring the use of dressings * Acute wound size between 3 cm² and 24 cm² (wound could be covered by 2 investigational products maximum) * Wound whose duration is ≤ 3 days * Both gender with an age ≥ 18 years * Written confirmation from the study nurse that the patient was informed, orally agreed to participate and to comply with study treatment and planned visits * Subject able to follow the protocol Exclusion Criteria: * Chronic and acute surgical wound * Infected, moderately to strongly exudative and haemorrhagic wound * Diagnosed underlying disease (e.g. diabetic neuropathy, stroke, etc.) which as judged by the investigator could interfere with the pain assessment * Known allergy/hypersensitivity to any of the components of the investigational products * Participation in other clinical investigation within one month prior to start of investigation * Pregnant or breast-feeding women * Person protected by a legal regime (tutorship or guardianship) * Patients unable to manifest an oral consent to participate (e.g. dementia) or to understand the use of the VAS (visual analogue scale) tool * Patient not covered by health insurance/social security

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute wounds are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CICA+

    Limonest, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.